Good Governance Board of Directors

Total Page:16

File Type:pdf, Size:1020Kb

Good Governance Board of Directors GOOD OVERVIEW GOVERNANCE Maintaining high standards of governance underpins everything we do, ensuring STRATEGY our people and operations behave responsibly. MARK WILLIAMSON Chairman PERFORMANCE DEAR SHAREHOLDER ENSURING OUR ANNUAL REPORT IS FAIR, This Corporate Governance Report details our approach to BALANCED AND UNDERSTANDABLE governance and the responsible way we run our business. A number of long-established and embedded processes In what proved to be a difficult year for the Group, strong underpin the key compliance requirement for our Annual Board oversight was vitally important. A major focus of Report to be fair, balanced and understandable. These include: this was the discussions relating to the best allocation of drafting of the Annual Report by appropriate senior resources to continue driving our strategy. These included management who monitor regulatory changes, are briefed approving our revised dividend policy, the commencement regarding the fair, balanced and understandable regulations of a share buyback programme, our asset divestment and ensure consistency throughout the report; GOVERNANCE programme and our investment in Auxly Cannabis Group Inc. extensive verification process undertaken to ensure factual accuracy and a fair presentation of our performance; We have also been focusing on Board succession, welcoming reviewing the use of adjusted measures and their Sue Clark and Jon Stanton to the Board and looking to appoint appropriateness in aiding users of our financial statements suitable successors for both myself and Alison Cooper, who to better understand our performance year-on-year; consideration and review of an advanced draft by Internal we announced in October will step down after 20 years with Audit and the Disclosure Committee to ensure accurate and the Company, the last nine of which have been as CEO. After balanced disclosure; eight years on the Board Malcolm Wyman retired in May 2019 comprehensive reviews of drafts of the Annual Report with our thanks and best wishes for the future. undertaken by members of the OPEX and other senior management; Whilst we have applied and were fully compliant with the the Audit Committee discussing the draft Annual Report requirements of the 2016 UK Corporate Governance Code with both management and our auditors PwC and, where throughout the year, we have adopted several provisions appropriate, challenging the content and any judgements FINANCIALS from the 2018 Code early, including my intention to step down and assumptions used; from the Board and the appointment of Steven Stanbrook as all Board members receiving drafts of the Annual Report with our Workforce Engagement Director. We will report on our sufficient time for review and comment prior to the year-end application of the 2018 Code in next year’s Annual Report. meetings in October 2019; and the Audit Committee reviewing the final draft at its meeting in Details of the Company’s governance framework and how it October 2019 at which time it was required to express its opinion underpins the delivery of our sustainable growth agenda are prior to consideration by the Board. set out in the following sections. After consideration of the above processes and review of the Annual Report, the Directors confirm that they consider, taken as a whole, that it is fair, balanced and understandable and provides the information necessary for shareholders to assess the Company’s position and performance, business model and strategy. MARK WILLIAMSON Chairman www.imperialbrandsplc.comwww.imperialbrandsplc.com 41 BOARD OF DIRECTORS MARK WILLIAMSON, CA (SA) Appointment Chairman of the Board Appointed to the Board of Directors in October 2013 and became Chief Financial Skills and experience Officer in November 2013. Mark is a qualified accountant, who External appointments brings considerable financial and general managerial experience to our Board. Mark No external Director appointments. was Chief Financial Officer of International Power plc until 2012 and is experienced in MATTHEW PHILLIPS, LLB managing relationships with the investor Chief Development Officer and financial communities. He is also a Mark Williamson D N Chairman former Senior Independent Non-Executive Skills and experience Director and Chairman of the Audit Matthew held a number of senior roles Committee of Alent PLC. prior to his appointment to the Board as Corporate Affairs Director in June 2012 and Appointment has been integral to the development and Mark joined the Board in July 2007 and implementation of the Group’s strategy. was appointed Senior Independent Non- In his current role he is responsible for NGP Executive Director in February 2012. He was innovation, product science, smokeless subsequently appointed Deputy Chairman tobacco, corporate development and of the Board in January 2013 before being corporate and legal affairs. made Chairman in February 2014. In anticipation of the requirements of Appointment the new UK Corporate Governance Code Appointed Director in June 2012. Appointed Alison Cooper E regarding a Chairman’s tenure on a Board, Chief Development Officer in June 2015. the Company announced in February 2019 External appointments that it had initiated a process to search for a Non-Executive Chairman to succeed Mark. No external Director appointments. External appointments SUE CLARK 1 Chairman of Spectris plc and Senior Non-Executive Director Independent Non-Executive Director and Chairman of the Audit Committee Skills and experience 1 of National Grid plc . Sue has strong international business credentials with over 20 years’ Executive ALISON COOPER, BSC, ACA Committee and Board level experience in Chief Executive Officer the FMCG, regulated transport and utility sectors. Sue held the role of Managing Oliver Tant E Skills and experience Director of SABMiller Europe and was an Alison is leading the business through Executive Committee member of SABMiller a transformative period in its history. plc. She joined SABMiller in 2003 as Having successfully implemented our Corporate Affairs Director and was part of tobacco strategy, she is now also focused the executive team that built the business on accelerating our growth in Next into a top five FTSE company. Generation Products, which represents Appointment a substantial additive opportunity for Imperial. Alison joined the Company Appointed Non-Executive Director in 1999 and, through a number of senior in December 2018 and Chair of the roles prior to her appointment as Chief Remuneration Committee in February 2019. Executive, has made a substantial External appointments contribution to our international expansion. Non-Executive Director and Chairman of Matthew Phillips E Appointment the Remuneration Committee of Britvic plc1, Non-Executive Director and member Appointed Director in July 2007. Appointed Chief Executive in May 2010. of the Audit and Remuneration Committees of Bakkavor Group plc1 and a member of External appointments the Supervisory Board and Remuneration No external Director appointments. Committee of AkzoNobel N.V1. Sue is also a Non-Executive Director of Tulchan OLIVER TANT, BSC, CA Communications LLP2. (SCOTLAND) Chief Financial Officer Skills and experience Sue Clark D N R Chairman Oliver held a number of senior positions in a 32-year career at KPMG, including Global Managing Director Financial KEY Advisory and Private Equity Division and Head of UK Audit. E Executive Director He was also a member of both the UK D Non-Executive Director and German boards of KPMG. He brings S Company Secretary to Imperial international experience in change management, organisational N Succession and Nominations restructuring, corporate finance and Committee mergers and acquisitions. A Audit Committee In his current role he is responsible R Remuneration Committee for finance, treasury, investor relations, 1. Public listed company procurement and information technology. 2. Private organisation 42 Imperial Brands Brands | Annual Annual Report Report and and Accounts Accounts 2019 2019 CHAIRMAN’S INTRODUCTION - GOVERNANCE THÉRÈSE ESPERDY External appointments OVERVIEW Non-Executive Director of Cott Corporation1 Senior Independent and Group 1 Automotive Inc1. Steven is also Non-Executive Director a Partner of Wind Point Partners2 and a Skills and experience Director of The Vollrath Company LLC2. Thérèse has significant international investment banking experience having JON STANTON held a number of roles at JP Morgan Non-Executive Director including Global Chairman of JP Morgan’s Financial Institutions Group, Co-Head Skills and experience of Asia-Pacific Corporate & Investment Jon has a wide range of experience, with Thérèse Esperdy D A N Banking, Global Head of Debt Capital a first-class international business track Markets, and Head of US Debt Capital record, including significant US exposure. Markets. She began her career at Lehman In 2016 he was appointed Chief Executive STRATEGY Brothers and joined Chase Securities of Weir Group PLC, having previously been in 1997 prior to the firm’s merger with CFO from 2010. Prior to that he spent 22 JP Morgan in 2000. years at Ernst & Young, LLP, the last nine She also meets the recent and relevant years of which were as an audit partner. financial experience requirements of the Appointment UK Corporate Governance Code. Appointed Non-Executive Director in Appointment May 2019. Appointed Senior Independent Non- External appointments Executive Director in May 2019 having 1 Simon Langelier D A N joined the Board in July 2016. Chief Executive of Weir
Recommended publications
  • Ethics Agreement in Order to Avoid Any Financial Conflict
    Date: 7 .-e-•15 Iett..% 1--4 17 MEMORANDUM FOR THE RECORD SUBJECT: Ethics Agreement In order to avoid any financial conflict of interest in violation of 18 U.S.C. § 208(a) or the appearance of a financial conflict of interest as defined in the Standards of Ethical Conduct for Employees of the Executive Branch, 5 C.F.R. § 2635.502, and to adhere to the Ethics Pledge instituted by Executive Order 13770 issued on January 28, 2017, and entitled "Ethics Commitments by Executive Branch Appointees" (the Ethics Pledge), I am issuing the following statement. I understand that as an appointee I must sign the Ethics Pledge and that I will be bound by the requirements and restrictions therein even if not specifically mentioned in this or any other ethics agreement. Before beginning my covered Federal position, I resigned from my non-Federal positions with the Association of State and Territorial Health Officials (ASTHO) and the State of Georgia on July 6, 2017. Pursuant to the Ethics Pledge, I will not, for a period of two years from the date of my appointment to my covered Federal position, participate in an official capacity in any particular matter involving specific parties that is directly and substantially related to ASTHO, unless an exception applies or I am granted a waiver. I understand that this provision in the Ethics Pledge does not apply to state government entities, including the State of Georgia. Even when the two-year restriction of the Ethics Pledge does not apply, under 5 C.F.R. § 2635.502, I will not, for a period of one year from the date of my resignation from ASTHO and the State of Georgia, participate in any particular matter involving specific parties in which ASTHO or the State of Georgia is a party or represents a party, unless I am first authorized to participate, pursuant to 5 C.F.R.
    [Show full text]
  • Annual Report and Accounts 2019
    IMPERIAL BRANDS PLC BRANDS IMPERIAL ANNUAL REPORT AND ACCOUNTS 2019 ACCOUNTS AND REPORT ANNUAL ANNUAL REPORT AND ACCOUNTS 2019 OUR PURPOSE WE CAN I OWN Our purpose is to create something Everything See it, seize it, is possible, make it happen better for the world’s smokers with together we win our portfolio of high quality next generation and tobacco products. In doing so we are transforming WE SURPRISE I AM our business and strengthening New thinking, My contribution new actions, counts, think free, our sustainability and value creation. exceed what’s speak free, act possible with integrity OUR VALUES Our values express who we are and WE ENJOY I ENGAGE capture the behaviours we expect Thrive on Listen, challenge, share, make from everyone who works for us. make it fun connections The following table constitutes our Non-Financial Information Statement in compliance with Sections 414CA and 414CB of the Companies Act 2006. The information listed is incorporated by cross-reference. Additional Non-Financial Information is also available on our website www.imperialbrands.com. Policies and standards which Information necessary to understand our business Page Reporting requirement govern our approach1 and its impact, policy due diligence and outcomes reference Environmental matters • Occupational health, safety and Environmental targets 21 environmental policy and framework • Sustainable tobacco programme International management systems 21 Climate and energy 21 Reducing waste 19 Sustainable tobacco supply 20 Supporting wood sustainability
    [Show full text]
  • Imperial Tobacco Group Plc Annual Report and Accounts
    IMPERIAL TOBACCO GROUP PLC ANNUAL REPORT AND ACCOUNTS 2003 02 FINANCIAL HIGHLIGHTS 03 PERFORMANCE 05 INTERNATIONAL 06 COST FOCUS 08 BRANDS 10 ACQUISITIONS 12 CHAIRMAN’S STATEMENT 15 CHIEF EXECUTIVE’S COMMITTEE 17 OPERATING AND FINANCIAL REVIEW 30 OPERATING ENVIRONMENT 34 BOARD OF DIRECTORS 36 SHAREHOLDER INFORMATION 37 REPORT OF THE DIRECTORS 39 CORPORATE GOVERNANCE 45 DIRECTORS’ REMUNERATION REPORT 57 INDEPENDENT AUDITORS’ REPORT TO THE MEMBERS OF IMPERIAL TOBACCO GROUP PLC 58 CONSOLIDATED PROFIT AND LOSS ACCOUNT 58 STATEMENT OF TOTAL RECOGNISED GAINS AND LOSSES 59 CONSOLIDATED BALANCE SHEET 60 CONSOLIDATED CASH FLOW STATEMENT 61 ACCOUNTING POLICIES 63 NOTES TO THE ACCOUNTS 96 IMPERIAL TOBACCO GROUP PLC BALANCE SHEET 97 NOTES TO THE IMPERIAL TOBACCO GROUP PLC BALANCE SHEET 99 PRINCIPAL SUBSIDIARIES Imperial Tobacco is the world’s fourth largest international tobacco company which manufactures, markets and sells a comprehensive range of cigarettes, tobaccos, rolling papers and cigars. ITG 01 The consistent application of our strategy has delivered compound annual growth in adjusted earnings per share of 18% and in dividends per share of 15% since 1997. FINANCIAL HIGHLIGHTS (In £’s million) 2003 2002 2001 2000 1999 Turnover 11,412 up 38% 8,296 5,918 5,220 4,494 Operating profit 881 up 46% 603 604 560 518 Adjusted operating profit 1 1,135 up 44% 789 619 568 518 Pre-tax profit 656 up 55% 423 494 450 400 Adjusted pre-tax profit 1 898 up 40% 642 509 458 400 Profit after tax 424 up 50% 283 355 323 287 Adjusted profit after tax 1 655 up 41% 465 370 331 287 (In pence) 2003 2002 2001 2000 1999 Basic earnings per share 58.1 up 42% 41.0 56.6 52.3 46.4 Adjusted earnings per share 1 90.0 up 32% 68.4 59.0 53.6 46.4 Diluted earnings per share 57.9 up 42% 40.8 56.2 52.0 46.1 Dividend per share 42.0 up 27% 33.0 28.8 26.4 23.0 1 Adjusted to exclude the effect of amortisation and exceptional items.
    [Show full text]
  • Current Research in Toxicology 1 (2020) 161–173
    Current Research in Toxicology 1 (2020) 161–173 Contents lists available at ScienceDirect Current Research in Toxicology journal homepage: www.elsevier.com/locate/crtox The use of human induced pluripotent stem cells to screen for developmental toxicity potential indicates reduced potential for non-combusted products, when compared to cigarettes ⇑ Liam Simms a, , Kathryn Rudd a, Jessica Palmer c, Lukasz Czekala a, Fan Yu a, Fiona Chapman a, Edgar Trelles Sticken b, Roman Wieczorek b, Lisa Maria Bode b, Matthew Stevenson a, Tanvir Walele a a Imperial Brands PLC, 121 Winterstoke Road, Bristol BS3 2LL, UK b Reemtsma Cigarettenfabriken GmbH, An Imperial Brands PLC Company, Albert-EinsteinRing-7, D-22761 Hamburg, Germany c Stemina Biomarker Discovery Inc., 504 S. Rosa Rd., Madison, WI 53719, USA ARTICLE INFO ABSTRACT Keywords: devTOX quickPredict (devTOXqP) is a metabolomics biomarker‐based assay that utilises human induced E‐cigarettes pluripotent stem (iPS) cells to screen for potential early stage embryonic developmental toxicity in vitro. Developmental toxicity Developmental toxicity potential is assessed based on the assay endpoint of the alteration in the ratio of key Cigarettes unrelated biomarkers, ornithine and cystine (o/c). Nicotine This work aimed to compare the developmental toxicity potential of tobacco‐containing and tobacco‐free Human induced pluripotent stem cells non‐combustible nicotine products to cigarette smoke. Smoke and aerosol from test articles were produced In vitro reproduction assay using a Vitrocell VC10 smoke/aerosol exposure system and bubbled into phosphate buffered saline (bPBS). iPS cells were exposed to concentrations of up to 10% bPBS. Assay sensitivity was assessed through a spiking study with a known developmental toxicant, all‐trans‐retinoic acid (ATRA), in combination with cigarette smoke extract.
    [Show full text]
  • Massmutual Short Duration Bond.Xlsx
    Fund Holdings As of 6/30/2021 MassMutual Short-Duration Bond Fund Barings Prior to 5/1/2021, the Fund name was MassMutual Premier Short-Duration Bond Fund. Fund Position Market Security Name Weighting % Value Us 10yr Note (Cbt)sep21 Xcbt 20210921 23.43 44,652,500 USTREAS T-Bill Auction Ave 3 Mon 5.24 9,987,667 Avis Budget Rental Car Funding AESOP LLC 3.02% 2.80 5,340,681 Goldman Sachs Group, Inc. 4.25% 2.79 5,319,704 Fna VI LLC 1.35% 2.22 4,229,828 COLLEGE AVE STUDENT LOANS LLC 2.32% 1.79 3,409,152 Adani Ports & Special Economic Zone 3.38% 1.71 3,251,532 Tower Bersama Infrastructure Tbk Pt 4.25% 1.70 3,235,134 Citigroup Inc. 4.4% 1.64 3,128,408 Country Garden Holdings Company Limited 8% 1.62 3,080,136 STARWOOD MORTGAGE RESIDENTIAL TRUST 1.53% 1.61 3,073,822 SOFI CONSUMER LOAN PROGRAM TRUST 3.89% 1.60 3,054,751 Occidental Petroleum Corporation 5.5% 1.58 3,008,904 Li & Fung LTD 4.5% 1.55 2,952,486 Avis Budget Rental Car Funding AESOP LLC 3.15% 1.51 2,875,133 Nelnet Student Loan Trust 1.5% 1.46 2,773,573 BX COMMERCIAL MORTGAGE TRUST 2.07% 1.45 2,760,068 Petroleos Mexicanos 4.62% 1.44 2,750,387 Vale Overseas Limited 6.25% 1.41 2,691,164 CARVANA AUTO RECEIVABLES TRUST 1.5% 1.39 2,644,293 Kref 2018-FL1 Ltd / Kref 2018-FL1 LLC 1.43% 1.36 2,600,819 Bpce Sa 5.7% 1.34 2,562,527 Residential Asset Mortgage Products, Inc.
    [Show full text]
  • Annex 1: Parker Review Survey Results As at 2 November 2020
    Annex 1: Parker Review survey results as at 2 November 2020 The data included in this table is a representation of the survey results as at 2 November 2020, which were self-declared by the FTSE 100 companies. As at March 2021, a further seven FTSE 100 companies have appointed directors from a minority ethnic group, effective in the early months of this year. These companies have been identified through an * in the table below. 3 3 4 4 2 2 Company Company 1 1 (source: BoardEx) Met Not Met Did Not Submit Data Respond Not Did Met Not Met Did Not Submit Data Respond Not Did 1 Admiral Group PLC a 27 Hargreaves Lansdown PLC a 2 Anglo American PLC a 28 Hikma Pharmaceuticals PLC a 3 Antofagasta PLC a 29 HSBC Holdings PLC a InterContinental Hotels 30 a 4 AstraZeneca PLC a Group PLC 5 Avast PLC a 31 Intermediate Capital Group PLC a 6 Aveva PLC a 32 Intertek Group PLC a 7 B&M European Value Retail S.A. a 33 J Sainsbury PLC a 8 Barclays PLC a 34 Johnson Matthey PLC a 9 Barratt Developments PLC a 35 Kingfisher PLC a 10 Berkeley Group Holdings PLC a 36 Legal & General Group PLC a 11 BHP Group PLC a 37 Lloyds Banking Group PLC a 12 BP PLC a 38 Melrose Industries PLC a 13 British American Tobacco PLC a 39 Mondi PLC a 14 British Land Company PLC a 40 National Grid PLC a 15 BT Group PLC a 41 NatWest Group PLC a 16 Bunzl PLC a 42 Ocado Group PLC a 17 Burberry Group PLC a 43 Pearson PLC a 18 Coca-Cola HBC AG a 44 Pennon Group PLC a 19 Compass Group PLC a 45 Phoenix Group Holdings PLC a 20 Diageo PLC a 46 Polymetal International PLC a 21 Experian PLC a 47
    [Show full text]
  • DWS CROCI International
    Investment Portfolio as of March 31, 2021 (Unaudited) DWS CROCI® International VIP Shares Value ($) Common Stocks 96.0% Australia 9.1% Australia & New Zealand Banking Group Ltd. 84,659 1,814,028 BHP Group Ltd. 110,251 3,815,874 Commonwealth Bank of Australia 4,288 280,930 National Australia Bank Ltd. 62,344 1,234,218 Newcrest Mining Ltd. 15,865 297,603 (Cost $5,536,400) 7,442,653 Belgium 1.6% UCB SA (Cost $1,072,787) 13,795 1,312,687 Denmark 3.0% AP Moller - Maersk AS “B” 870 2,024,140 Novo Nordisk AS “B” 7,052 474,954 (Cost $1,948,110) 2,499,094 Finland 1.0% Fortum Oyj 12,738 340,652 Nokia Oyj* 121,910 486,937 (Cost $695,418) 827,589 France 14.1% Atos SE* 22,260 1,739,792 BNP Paribas SA* 53,894 3,290,488 Credit Agricole SA* 118,678 1,721,985 Engie SA* 79,187 1,127,334 Sanofi 30,370 3,003,484 Television Francaise 1* 80,739 737,194 (Cost $9,733,297) 11,620,277 Germany 8.4% Beiersdorf AG 12,876 1,355,372 Brenntag SE 13,966 1,193,987 Deutsche Boerse AG 4,043 672,742 Deutsche Post AG (Registered) 23,524 1,291,802 Fresenius Medical Care AG & Co. KGaA 7,353 542,699 Fresenius SE & Co. KGaA 10,857 484,249 HeidelbergCement AG 5,007 455,278 Merck KGaA 3,152 539,013 SAP SE 2,641 324,172 (Cost $6,246,907) 6,859,314 Hong Kong 0.7% CLP Holdings Ltd.
    [Show full text]
  • QAD CLOUD IMPERIAL TOBACCO ROI: 72% Payback: 4.8 Months
    ROI CASE STUDY P R O G R A M : ENTERPRISE APPLICATI ONS DOCUMENT NUMBER: S179 NOVEMBER 2 0 1 8 ROI: 72% Payback: 4.8 Months QAD CLOUD IMPERIAL TOBACCO ANALYST Seth Lippincott THE BOTTOM LINE Imperial Tobacco shifted its existing QAD production environment to the cloud rather than upgrading and refreshing its on-premises infrastructure, reducing its project costs by over seven million pounds. With its current environment reaching its end-of-life, Imperial Tobacco built a business case to upgrade to the latest version of QAD deployed on premises. However, by opting to lift and shift to the cloud, the company was able to extend the life of its current solution and lay the foundation for any future upgrade to the cloud. Imperial Tobacco was able to reduce its costs related to maintenance, development and technical staff, and technology hosting. ©2018 Nucleus Research Inc. | 100 State Street, Boston, MA, 02109 | +1 (617) 720-2000 | NucleusResearch.com 1 THE COMPANY Imperial Tobacco is comprised of several manufacturing subsidiaries that produce and market a range of tobacco products and accessories. With a long heritage in the tobacco industry and locations in the UK, Poland, Russia, Germany, Spain, and Australia, Imperial Tobacco makes brands that are available in markets around the world including West, JPS, Golden Virginia, Davidoff, and Gauloises Blondes. Imperial Tobacco is one of five subsidiaries of Imperial Brands, which has diversified into next generation products as well as owning a traditional tobacco portfolio. THE CHALLENGE In early 2017, Imperial Tobacco faced a dilemma about how to move forward with its global production environment.
    [Show full text]
  • Constituents & Weights
    2 FTSE Russell Publications 19 August 2021 FTSE 100 Indicative Index Weight Data as at Closing on 30 June 2021 Index weight Index weight Index weight Constituent Country Constituent Country Constituent Country (%) (%) (%) 3i Group 0.59 UNITED GlaxoSmithKline 3.7 UNITED RELX 1.88 UNITED KINGDOM KINGDOM KINGDOM Admiral Group 0.35 UNITED Glencore 1.97 UNITED Rentokil Initial 0.49 UNITED KINGDOM KINGDOM KINGDOM Anglo American 1.86 UNITED Halma 0.54 UNITED Rightmove 0.29 UNITED KINGDOM KINGDOM KINGDOM Antofagasta 0.26 UNITED Hargreaves Lansdown 0.32 UNITED Rio Tinto 3.41 UNITED KINGDOM KINGDOM KINGDOM Ashtead Group 1.26 UNITED Hikma Pharmaceuticals 0.22 UNITED Rolls-Royce Holdings 0.39 UNITED KINGDOM KINGDOM KINGDOM Associated British Foods 0.41 UNITED HSBC Hldgs 4.5 UNITED Royal Dutch Shell A 3.13 UNITED KINGDOM KINGDOM KINGDOM AstraZeneca 6.02 UNITED Imperial Brands 0.77 UNITED Royal Dutch Shell B 2.74 UNITED KINGDOM KINGDOM KINGDOM Auto Trader Group 0.32 UNITED Informa 0.4 UNITED Royal Mail 0.28 UNITED KINGDOM KINGDOM KINGDOM Avast 0.14 UNITED InterContinental Hotels Group 0.46 UNITED Sage Group 0.39 UNITED KINGDOM KINGDOM KINGDOM Aveva Group 0.23 UNITED Intermediate Capital Group 0.31 UNITED Sainsbury (J) 0.24 UNITED KINGDOM KINGDOM KINGDOM Aviva 0.84 UNITED International Consolidated Airlines 0.34 UNITED Schroders 0.21 UNITED KINGDOM Group KINGDOM KINGDOM B&M European Value Retail 0.27 UNITED Intertek Group 0.47 UNITED Scottish Mortgage Inv Tst 1 UNITED KINGDOM KINGDOM KINGDOM BAE Systems 0.89 UNITED ITV 0.25 UNITED Segro 0.69 UNITED KINGDOM
    [Show full text]
  • Imperial Tobacco Finance
    Prospectus Imperial Tobacco Finance PLC A9.4.1.1 (Incorporated with limited liability in England and Wales with registered number 03214426) A9.4.1.2 Imperial Tobacco Finance France SAS (A société par actions simplifiée incorporated in France) €15,000,000,000 Debt Issuance Programme Irrevocably and unconditionally guaranteed by Imperial Tobacco Group PLC A9.4.1.1 (Incorporated with limited liability in England and Wales with registered number 03236483) A9.4.1.2 This Prospectus amends, restates and supersedes the offering circular dated 21st February 2014. Any Notes issued after the date hereof under the Debt Issuance Programme described in this Prospectus (the “Programme”) are issued subject to the provisions set out herein. This Prospectus will not be effective in respect of any Notes issued under the Programme prior to the date hereof. Under the Programme, Imperial Tobacco Finance PLC (“Imperial Finance” or an “Issuer”) and Imperial Tobacco Finance France SAS A6.1 (“Imperial Finance France” or an “Issuer” and together with Imperial Finance “the Issuers”), subject to compliance with all relevant laws, regulations and directives, may from time to time issue debt securities (the “Notes”) guaranteed by Imperial Tobacco Group PLC (“Imperial Tobacco” or the “Guarantor”) and Imperial Tobacco Limited (“ITL”). Please see the Trust Deed dated 6th February 2015 (the “Trust Deed”) which is available for viewing by Noteholders as described on page 124 for further details about the Imperial Tobacco guarantee and page 98 for further details regarding the ITL guarantee. The aggregate nominal amount of Notes outstanding will not at any time exceed €15,000,000,000 (or the equivalent in other currencies).
    [Show full text]
  • International Value Fund Q3 Portfolio Holdings
    Putnam International Value Fund The fund's portfolio 3/31/21 (Unaudited) COMMON STOCKS (96.1%)(a) Shares Value Aerospace and defense (0.7%) BAE Systems PLC (United Kingdom) 137,249 $955,517 955,517 Airlines (1.2%) Qantas Airways, Ltd. (voting rights) (Australia)(NON) 437,675 1,698,172 1,698,172 Auto components (1.5%) Magna International, Inc. (Canada) 23,813 2,097,257 2,097,257 Automobiles (1.2%) Yamaha Motor Co., Ltd. (Japan) 70,500 1,742,181 1,742,181 Banks (14.7%) AIB Group PLC (Ireland)(NON) 708,124 1,861,795 Australia & New Zealand Banking Group, Ltd. (Australia) 165,820 3,561,114 BNP Paribas SA (France)(NON) 28,336 1,723,953 CaixaBank SA (Spain) 295,756 915,292 DBS Group Holdings, Ltd. (Singapore) 60,800 1,311,573 DNB ASA (Norway) 71,016 1,511,129 Hana Financial Group, Inc. (South Korea) 38,370 1,447,668 ING Groep NV (Netherlands) 362,345 4,432,786 Lloyds Banking Group PLC (United Kingdom)(NON) 1,014,265 594,752 Mizuho Financial Group, Inc. (Japan) 73,920 1,066,055 Skandinaviska Enskilda Banken AB (Sweden)(NON) 30,210 368,223 Sumitomo Mitsui Financial Group, Inc. (Japan) 67,400 2,450,864 21,245,204 Beverages (1.0%) Asahi Group Holdings, Ltd. (Japan) 33,700 1,426,966 1,426,966 Building products (1.1%) Compagnie De Saint-Gobain (France)(NON) 27,404 1,617,117 1,617,117 Capital markets (3.6%) Partners Group Holding AG (Switzerland) 1,115 1,423,906 Quilter PLC (United Kingdom) 798,526 1,759,704 UBS Group AG (Switzerland)(NON) 132,852 2,057,122 5,240,732 Chemicals (1.1%) LANXESS AG (Germany) 21,951 1,618,138 1,618,138 Construction and engineering (2.5%) Vinci SA (France) 35,382 3,624,782 3,624,782 Construction materials (1.2%) CRH PLC (Ireland) 38,290 1,794,760 1,794,760 Containers and packaging (0.8%) SIG Combibloc Group AG (Switzerland) 51,554 1,192,372 1,192,372 Diversified financial services (2.1%) Eurazeo SA (France)(NON) 20,542 1,563,415 ORIX Corp.
    [Show full text]
  • Big Tobacco, Big Avoidance Report 2020 1
    Big Tobacco, Big Avoidance report 2020 1 Big Tobacco, Big Avoidance An analysis of the main tax avoidance structures used by British American Tobacco, Imperial Brands, Japan Tobacco International and Philip Morris International, based on annual reports of parent companies and major subsidiaries in 2010-2019 4 November 2020 A cooperative of highly specialized investigative journalists The Investigative Desk is a cooperative of highly specialised investigative journalists Office: Gaasterlandstraat 5, 1079 RH Amsterdam, the Netherlands +31 6 54674124 / www.investigativedesk.com / [email protected] Big Tobacco, Big Avoidance report 2020 2 Authors: Stefan Vermeulen (TheID) Manon Dillen (TheID) Co-author: Dr. J Robert Branston, Senior Lecturer (Associate Professor) in Business Economics School of Management, University of Bath, UK Researchers: Sergio Nieto Solis (TheID) Nadia el Khannoussi (TheID) Editor-in-chief and supervisor: Dr. Marcel Metze (TheID) The Investigative Desk is a cooperative of highly specialised investigative journalists Office: Gaasterlandstraat 5, 1079 RH Amsterdam, the Netherlands +31 6 54674124 / www.investigativedesk.com / [email protected] Big Tobacco, Big Avoidance report 2020 3 Summary of key findings There is growing pressure worldwide for companies to pay their fair share of tax. One sector that has lucrative revenue and profits is the tobacco industry (see chart). Although the sector makes billions in revenue, it pays relatively little in corporate taxes. Tobacco’s Big Four transnational companies - British American Tobacco, Imperial Brands, Japan Tobacco and Philip Morris - make extensive use of the entire range of common tax avoidance methods. We did not find any clear evidence of illegal practices (tax evasion), but analysis of their annual reports and those of a number of crucial subsidiaries in the period 2010-2019 shows that all four have ‘aggressive tax planning’ strategies, in spite of their own codes of conduct suggesting otherwise.
    [Show full text]